Labgene PSA Rapid Card - Pack of 25 Tests (LG037-25T)

Description

The Labgene PSA Rapid Card is an innovative diagnostic device designed for the rapid and reliable detection of prostate-specific antigen (PSA) in human serum or plasma samples. Utilizing advanced immunochromatographic technology, this rapid test provides accurate results within minutes, enabling timely diagnosis and monitoring of prostate cancer. The PSA Rapid Card features a user-friendly design, making it suitable for point-of-care testing in various healthcare settings.

Key Features

• High Sensitivity and Specificity: Demonstrates high sensitivity and specificity in detecting prostate-specific antigen (PSA), ensuring reliable diagnostic performance.
• Immunochromatographic Technology: Utilizes advanced immunochromatography for sensitive and specific detection of PSA in human samples.
• Rapid Results: Provides fast and accurate results within minutes, facilitating immediate clinical decision-making and patient management.
• User-Friendly Design: Compact and easy to use, with clear result interpretation guidelines, making it suitable for use by healthcare professionals at the point of care.
• Quantitative Measurement: Provides semi-quantitative measurement of PSA levels, allowing for the monitoring of disease progression and treatment efficacy.
• Room Temperature Storage: Can be stored at room temperature, eliminating the need for refrigeration and enhancing convenience and accessibility.

Benefits

• Early Detection and Monitoring: Enables early detection and monitoring of prostate cancer by measuring PSA levels in human serum or plasma samples.
• Point-of-Care Testing: Allows for convenient testing at the point of care, reducing turnaround time and enabling immediate clinical decision-making.
• Accurate and Reliable: Demonstrates high accuracy and reliability, minimizing false-positive and false-negative results and ensuring accurate diagnosis.
• Convenient and Portable: Compact design and room temperature storage make it ideal for use in various healthcare settings, including primary care clinics, hospitals, and community health centers.
• Cost-Effective Screening: Offers a cost-effective screening solution for prostate cancer, particularly in regions where laboratory infrastructure is limited.
• Patient Privacy: Provides discreet testing options, promoting patient privacy and confidentiality during PSA screening.